Acura Pharmaceuticals provides an update on the development of LTX-03
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
On Mar. 23, 2020, Acura Pharmaceuticals announced that Abuse Deterrent Pharma, its licensee of LTX-03 (Hydrocodone Bitartrate and…
On Mar. 23, 2020, Harvard Bioscience announced that it had launched an innovative technology – known as Accumulated…
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
On Mar. 23, 2020, LabCorp announced that it was exploring all options to prioritize COVID-19 testing for the…
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
On Mar. 23, 2020, researchers from the University of Oxford announced they have launched a new clinical trial…
On Mar. 23, 2020, Resverlogix announced a bioRxiv publication that has shown apabetalone to inhibit specialized proteins –…
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
On Mar. 22, 2020, Royal Philips announced that it is increasing the production of certain critical care products and…
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
On Mar. 20, 2020, PRA Health Sciences announced the commercial availability of the COVID-19 Monitoring Program, a mobile…
On Mar. 20, 2020, Chembio Diagnostics announced receipt of a $4 million order from Bio-Manguinhos for the purchase…
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
On Mar. 19, 2020, Abbott announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA)…
On Mar. 19, 2020, Roche announced it was working with the U.S. Food & Drug Administration (FDA) to…
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
On Mar. 19, 2020, Mesa Biotech announced it has significantly expanded its capacity to test clinical samples for…
On Mar. 19, 2020, LabCorp announced it is dedicating the first hour of service each day at its…
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
On Mar. 19, 2020, iBio announced its progress towards developing vaccine candidates for preventing infection from the SARS-CoV-2…
On Mar. 19, 2020, Todos Medical announced it had entered into an exclusive distribution agreement for the U.S….